ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links0 made here, not in the record13 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03712202Brentuximab Vedotin andNivolumab in TreatingPatients With Early StageClassic Hodgkin LymphomaCity of Hope Medical CenterPhase 2 · active not recruitinRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 29 · ClinicalTrials.gov record · Version of 2026-10-29Version of 2026-10-29CONDITIONSHodgkin DiseaseThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSBleomycinIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundBrentuximab VedotinIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDacarbazineIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedDoxorubicinIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedVinblastineIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Bleomycin

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Bleomycin”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 29The record itselfClinicalTrials.gov recordVersion of 2026-10-29Record change
Nov 2BleomycinClaude Opus 5.5BackgroundCurrent
Nov 2Brentuximab VedotinClaude Opus 5.5TestedCurrent
Nov 2DacarbazineClaude Opus 5.5TestedCurrent
Nov 2DoxorubicinClaude Opus 5.5TestedCurrent
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2VinblastineClaude Opus 5.5TestedCurrent
Nov 18BleomycinRule based · role ruleBackgroundAgrees
Nov 18Brentuximab VedotinRule based · role ruleTestedAgrees
Nov 18DacarbazineRule based · role ruleTestedAgrees
Nov 18DoxorubicinRule based · role ruleTestedAgrees
Nov 18NivolumabRule based · role ruleTestedAgrees
Nov 18VinblastineRule based · role ruleTestedAgrees
As of nowHodgkin DiseaseRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.